drugset / Trial / NCT06430788
A Study of Emapalumab for Pediatric Aplastic Anemia
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to find out whether upfront emapalumab treatment can help in sAA (Aplastic Anemia) treatment planning and increase the effectiveness of standard treatment options. Funding Source- FDA OOPD
Timeline
- Start
- 2024-05-21
- Primary completion
- 2029-05-21
- Completion
- 2029-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emapalumab | Monoclonal antibody | — | — |